Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents

BACKGROUND AND AIMS: Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two approved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [IBD]. There are many potential new therapies being...

Descripción completa

Detalles Bibliográficos
Autores principales: Croft, Nicholas M, de Ridder, Lissy, Griffiths, Anne M, Hyams, Jeffrey S, Ruemmele, Frank M, Turner, Dan, Cheng, Katharine, Lutsar, Irja, Greco, Marco, Gołębiewska, Zuzanna, Laumond, Floriane, Cavaller-Bellaubi, Maria, Elgreey, Adam, Altepeter, Tara A, Pallidis, Chrissi, Norga, Koen, Nelson, Robert, Crandall, Wallace, Vassal, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024546/
https://www.ncbi.nlm.nih.gov/pubmed/36130314
http://dx.doi.org/10.1093/ecco-jcc/jjac135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024546/
https://www.ncbi.nlm.nih.gov/pubmed/36130314
http://dx.doi.org/10.1093/ecco-jcc/jjac135

Ejemplares similares